BMRA - Biomerica, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue5,791.675,139.8164,962.373
Cost of Revenue3,769.8793,615.7743,420.567
Gross Profit2,021.7911,524.0421,541.806
Operating Expenses
Research Development1,130.635780.333733.64
Selling General and Administrative1,845.7891,570.6611,478.761
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-954.633-826.952-670.595
Income from Continuing Operations
Total Other Income/Expenses Net46.35431.13224.161
Earnings Before Interest and Taxes-908.279-795.82-646.434
Interest Expense0.2820.1670.167
Income Before Tax-908.561-795.987-646.434
Income Tax Expense-703.8-315.024
Minority Interest---
Net Income From Continuing Ops-908.561-1,499.787-331.41
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-908.561-1,499.787-331.41
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-908.561-1,499.787-331.41